Finance
Men's health company reports $5.8M loss in first quarter
Published in Women's Health Weekly, May 20th, 2004
The total net loss for the quarter was $5.8 million, compared with a net loss of $2.8 million for the same period in 2003.
Research and development expenses increased 105% to $4.3 million for the first quarter of 2004 from $2.1 million for the first quarter of 2003. This increase was mainly attributable to planned expenditures related to the pivotal phase III clinical trial of ACAPODENE (Toremifene Citrate) tablets for the treatment of side...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Activism
March highlights global impact of U.S. reproductive health policies - Endocrinology
Testosterone replacement improves muscle strength, function in HIV+ women - Mammography
Women use different strategies to cope with the pain of mammograms - Obstetrics
Antenatal factors associated with maternal infection hamper infant neurology - Urinary Incontinence
Combinations of behavioral and drug therapy help patients with incontinence - Abortion
Utah hospital won't terminate pregnancies in cases of fatal fetal deformity - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
